A case-control study of breast cancer was conducted in Buffalo. Participants completed a food frequency questionnaire and donated a fasting blood sample before de finitive workup for breast masses. Dietary and plasma concen trations of carotenoids and retinol for 83 women found to have breast cancer were compared with those of 1 13 women found to be free of breast cancer (control subjects). There were no case-control differences in dietary estimates of vitamin A in take or in plasma a-carotene and lycopene. However, subjects with breast cancer had lower concentrations of plasma fj-carotene than did control subjects (P = 0.02). There was no overall association between plasma retinol and breast cancer but a pos itive relationship was observed between retinol and breast can cer in the subgroup with low fj-carotene values. These results suggest that low plasma fj-carotene is associated with increased risk of breast cancer. Other studies will need to determine whether low carotene concentrations are a subtle effect of the disease or might be causally related to breast cancer. A case-control study of breast cancer was conducted in Buffalo. Participants completed a food frequency questionnaire and donated a fasting blood sample before definitive workup for breast masses. Dietary and plasma concentrations of carotenoids and retinol for 83 women found to have breast cancer were compared with those of 1 13 women found to be free of breast cancer (control subjects). There were no case-control differences in dietary estimates of vitamin A intake or in plasma a-carotene and lycopene. However, subjects with breast cancer had lower concentrations of plasma fj-carotene than did control subjects (P = 0.02). There was no overall association between plasma retinol and breast cancer but a positive relationship was observed between retinol and breast cancer in the subgroup with low fj-carotene values. These results suggest that low plasma fj-carotene is associated with increased risk of breast cancer. Other studies will need to determine whether low carotene concentrations are a subtle effect of the disease or might be causally related to breast cancer.
Introduction
The roles of vitamin A and carotenes in carcinogenesis have been investigated in a large number of experimental systems ( I ). Supplemental retinyl acetate in animal diets may cause either a lower (2-8) or higher (9) incidence of mammary tumors whereas supplemental fj-carotene in the diet was shown to inhibit mammary tumors (10, 1 1) and transplantable tumors ( l 2).
butions from both preformed (retinol) and precursor (carotenes) vitamin A. Although results from some plasma studies ( 16, 20) indicated no association between breast cancer and fJ· carotene or total carotenoids. respectively, results from other blood studies ( 19, 25. 26) showed a nonsignificant inverse association between breast cancer and fj-carotene.
Overall, previous studies indicate either no association or a direct association between breast cancer and retinol and no association or an inverse association between carotenes and breast cancer. Some studies were not specifically designed to investigate breast cancer and suffered from inadequate power (19-21. 25 ) whereas others did not control for important breast cancer risk factors (20. 21, 23, 25. 26) or plasma lipids (19. 21, 25, 26) . These limitations may have diminished the ability to observe the effects of nutrients on cancer risk.
This case-control study was designed to assess the independent and interactive effects of preformed vitamin A and carotenoids in the plasma and in the diet, controlling for other risk factors and other nutrients.
Methods
Between September 1985 and September 1986, study subjects were enrolled from the breast clinic at Roswell Park Memorial Institute and from the offices of two private surgeons in Buffalo. Eligible patients were women aged 30-80 y who were being evaluated for a breast mass but who had no previous history of cancer. All participants had lived in upstate New York or Pennsylvania for I y. After subjects were scheduled for a diagnostic biopsy, informed consent was obtained and they were given a questionnaire and directions for the blood-collecEpidemiologic studies have indicated an inverse association between plasma retinol and risk of cancer of all sites ( 13, 14) , with only suggestive evidence for this association in breast cancer ( 15) . Three studies with dietary data (16) (17) (18) and three studies with plasma data (19) (20) (21) showed no association between breast cancer and retinol whereas one study with plasma showed a positive association ( 16) .
An inverse association was observed between breast cancer and estimates of dietary intake of carotenes ( 17) and vegetables (22) . One dietary study ( 18) showed no association whereas other dietary studies (23, 24) reported an inverse association between breast cancer and total vitamin A intake, with contri-tion procedure. The study was approved by the Clinical Investigations Committee at Roswell Park Memorial Institute and by Institutional Review Boards at the State University of New York at Buffalo and the Buffalo General Hospital. Thirty-four patients who were referred to the specialists because of a suspicious mammogram or lump but were determined not to have masses requiring biopsy were included in the control group.
Patients were classified into one of three groups on the basis of their pathology reports from the breast biopsies: subjects with breast cancer ( n = 83), control subjects ( n = 1 13), or excluded (n = 40). Women with breast cancer had cancers classified as 7% in situ, 32% stage I, 46% stage II, and 15% stages III or IV. The 1 13control subjects were those 79 women who were found to have benign lesions on biopsy , plus the 34 women who did not require a biopsy . The 40 patients with biopsy reports that described lesions and who were thought to be at increased risk of breast cancer (predominantly of an atypical hyperplastic nature) were excluded from the control group.
The self-administered questionnaire requested information about the subjects' dietary practices and medical history. A food frequency table with five frequency categories (never, rarely, 1-3 times/mo, 1-4 times/wk, and 5-7 times/wk) contained a list of 30 food items that previous analysis indicated would account for 90% of the variance associated with estimated vitamin A intake (27) . Standard portion sizes were assumed to convert the frequency data into estimates of nutrient intake.
Fasting blood samples were drawn from subjects before their biopsies were taken or on a designated day for the 34 patients who did not have biopsies taken . The samples were centrifuged at 2000 X g for 12 min and plasma was preserved in sodium ascorbate ( I 0 mg/mL plasma) and frozen at -80 °C until the end of the study. Blood was stored from 5 to 17 mo; storage duration was similar for women with breast cancer and control subjects. In addition, there were no trends observed concerning nutrient concentrations with length of storage. Blood specimens were thawed once for portioning of samples and once for the laboratory analysis. Retinol and carotenoids were analyzed by HPLC, retinol by a modification of a standard method (28) , and carotenoids by a modification of a new method (29) .
Statistical analysis
Statistical analyses were conducted with SYSTAT (version 3.0, Systat, Inc, Evanston, IL) and the supplementary logit program on an AT&T 6300 personal computer. Differences in means were tested with the Student's t test and differences in proportions were tested by logit analysis. In the latter analyses, case status was the independent variable, the breast-cancer risk factor was the dependent variable, and other breast-cancer risk factors were added to the model as needed. Nutrients were logtransformed and categorized into quartiles on the basis of their distribution in the control subjects. Multivariate analyses used logit analysis with case status as the dependent variable; there were three possible outcome categories but only the results for subjects with breast cancer vs control subjects are presented here. In the multivariate analyses the nonnutrient, breast-cancer risk factors used as covariates were age, age at menarche, age at menopause, age at first birth, parity, menopausal status, family history of breast cancer in a first-degree relative , Quetelet index (kg/m 2 ), marital status, and income. Analyses 
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Two highest income groups (%)"* 29 42
•x ± SD. BBD, benign breast disease.
t Significantly different from control subjects, P < 0.00 I .
* Total months in lifetime spent breast-feeding. § Percent of diagnostic group. U Percent of those menopausal. Self-reported history of a previous diagnosis of BBD. •• Two highest of seven income categories.
of the plasma retinol and carotenoid variables also controlled for plasma lipids to evaluate the effect of the nutrient of interest after differences in lipid status were eliminated. In addition, both triglycerides and cholesterol were associated with case status and therefore were potential confounding variables. Tests for trend used the continuous, log-transformed nutrient variable. The models and variables were assessed by use of the log likelihood ratio test and all significant predictors of case status were included in the full models, as well as the nonnutrient, breast-cancer risk factors.
Results
The characteristics of the subjects with breast cancer and control subjects at baseline are presented in Table 1 . Subjects with breast cancer were significantly older than the control subjects but were not statistically different from control subjects in any of the other potentially confounding variables. Subjects with breast cancer had significantly lower P-carotene and lycopene values than did control subjects (P < 0.01 and P < 0.05, respectively) ( Table 2) ; however, they did not have different mean values for retinol, a-carotene, or dietary estimates of vitamin A intake.
Multivariate analysis showed that low P-carotene was associated with an increased risk of breast cancer, with and without adjustment for plasma lipids (Table 3 ). Further analyses showed that the inverse association between P-carotene and breast cancer was restricted to the postmenopausal cases (test for trend P < 0.00 I ). Alpha-carotene was not associated with breast-cancer risk (Tables 2 and 3), and low concentrations of   TABLE 2 Comparison of plasma and dietary variables among subjects with breast cancer and control subjects* nificant. Although the other confidence intervals included unity, the trends indicated that within the other P-carotene quartiles, risk decreased as retinol increased. Multivariate analyses of the dietary data indicated no association between breast cancer and either total or vegetable vitamin A intakes (Table 5 ). There was no statistically significant interaction between total vitamin A and vegetable vitamin A.
Total dietary vitamin A was not correlated with plasma retinol ( r = 0.1 1) or P-carotene ( r = 0.16), nor was dietary vitamin A from vegetable sources correlated with plasma P-carotene ( r = -0.02). Plasma a-carotene, however, was marginally correlated with total dietary vitamin A ( r = 0.26).
Vegetable vitamin A (IU/d) I770 ± 2 400 1 900 ± 2 900 * x ± SD. tt Significantly different from cases: tP < 0.01, tP < 0.05. lycopene appeared to be associated with increased risk of breast cancer before controlling for plasma lipids. Lycopene was not associated with case status after controlling for these lipids.
The main effect of plasma retinol values indicated no association with breast-cancer risk (Table 3) ; however, a statistically significant interaction with plasma P-carotene (Table 4) showed a trend of increasing risk for breast cancer with increasing retinol within the low P-carotene quartile. The wide confidence intervals indicated few individuals with higher retinol and low P-carotene; even so, the results were statistically sig TABLE 3 Discussion
Control group
Many of the known breast-cancer risk factors were not more prevalent among subjects with breast cancer than among control subjects. Therefore, these control subjects would appear to be at high risk for breast cancer, according to known risk-factor classification for breast cancer, if they were compared with women in the general population. Thus, this study compared women with breast cancer with a group who had similarly high risk but who did not have breast cancer.
There are two possible biases of concern with this control group. The results may be biased towards a false-positive finding if the breast-cancer risk factors prevalent in this control group were also associated with nutrient status (eg, high carotOdds ratios (subjects with breast cancer vs control subjects) for plasma nutrient quartiles with adjustments for potential confounding variables with and without lipid adjustment* enoid consu mption). No evidence was found supporting an association between the benign breast disease prevalent in this control group and vitamin A or carotenoids (30) , and it is unlikely that other components of the high-risk classification (eg, age at menarche, age at first birth) are related to these nutrients. In contrast. the control subjects were very similar to subjects with breast cancer, by risk-factor classification which would bias the results towards a false-negative finding of no association. This is only of concern with the findings for a-carotene and lycopene. which were nonsignificant , but is not of concern with findings for ,B-carotene and retinol, which were significant. Indeed , the similarity between the groups may be a strength of the study because the analysis focused on factors that allowed control subjects to be free of cancer even though they were very similar to subjects with breast cancer in terms of other risk factors. A difference in nutritional status between these two groups would be of considerable interest because it would suggest a nutritional advantage among the control subjects very late in the promotional stages of the disease process. These results not only indicated that such a difference existed between these groups but also that the difference was in the same direction (low ,B-carotene, higher risk) as that frequently observed in earlier etiologic stages.
Plasma ,B-carotene
The concentrations of carotenoids in this study were relatively low compared with those in similar groups of women in the United States (31, 32) . Quality control plasma samples were exchanged between laboratories, which determined that our assay yielded values approximately one-half the values obtained by other standard methods (33, 34) because oflower extraction efficiency of the solvent. There was no evidence of differential loss by concentration of carotenoids, rather a loss of -50% at all concentrations. Therefore, the ordinal ranking of individuals would be similar to that provided by the higher absolute values. Carotene values are reported here in the original form because relative and not absolute values were used to support these types of statistical analyses.
The association of lower ,B-carotene concentrations with breast cancer may be confounded by alcohol intake, which was not measured in this study. Alcohol was associated with breast cancer in 12 studies (35-46) but not in 5 other studies (47) (48) (49) (50) (51) .
In addition, alcohol may be associated with lower plasma ,Bcarotene values (32, 52) although this effect has only been observed in men and it is unclear whether alcohol is directly related to lower ,B-carotene concentrations or is coincident with lower ,B-carotene intake. Further research is warranted to determine whether the association of plasma ,B-carotene values with breast cancer persist after controlling for alcohol consumption.
Although smoking has been associated with lower plasma ,Bcarotene (32, 52), it has not been associated with breast cancer (53) and therefore was not controlled in the analyses.
Lower plasma ,B-carotene values in the breast-cancer patients may also be a result of rather than a precursor of disease. A marginally significant trend (P = 0.08) of decreasing ,B-carotene values with increasing stage of disease was observed; this suggests that the disease may alter this blood variable. Alternatively, the patients with later-stage disease may have altered their intake to a greater degree than did the patients with earlier-stage disease. Although it is difficult to disentangle such results in a case-control study, there is some evidence from other studies against a metabolic alteration due to the disease. A prospective study in Britain ( 19) demonstrated that the subjects with breast cancer diagnosed within 2 y of blood collection did not have lower ,B-carotene concentrations than did subjects diagnosed later. In addition, there is no evidence from animal studies that tumors affect the concentrations of this nutrient whereas there is evidence that low ,B-carotene intake promotes mammary tumors ( I 0). However, further studies are needed to elucidate the possible affect of the disease on ,B-carotene concentrations.
Plasma ,B-carotene was shown to reflect dietary intake of ,Bcarotene (26, 54, 55) and total carotene intake (32, 52, 56) ; therefore, the lower ,B-carotene concentrations observed to be associated with case status may be of dietary origin. Although the dietary data from this study did not support this conclusion, results from larger dietary studies indicated that lower estimated intakes of total vitamin A (23) or ,8-carotene (17) were 19) the authors found lower plasma P-carotene values (NS) in women later diagnosed with breast cancer than in women who remained disease free. Although these findings were later questioned because of storage considerations (57), the present study corroborates these findings. In a preliminary report (26) the mean plasma Jj-carotene concentration of 30 women with metastatic breast cancer was 21% lower than in control subjects. Willett et al (20) did not find an association between breast cancer and plasma carotenoids; however. this study was limited by sample size ( n = 14 cases) and did not control for important confounding factors. In a case-control study in Italy ( 16), the authors did not find an association between breast cancer and plasma P-carotene values. The mean P-carotene values were relatively high in this population, which suggests that there were few individuals in the low range where the effect was observed in the present study (even if our values were doubled to allow for analytical extraction efficiency).
Alpha-carotene and lycopene
There was weak evidence of an association between a-carotene and the disease in the model that did not include Jj-carotene and lipids. However, the collinearity between P-carotene and a-carotene ( r = 0.71) made it difficult if not impossible to assess the independent a-carotene effect when both carotenoids were necessary in the full model. The larger range of Jj-carotene allowed it to predominate but this does not exclude the possibility of a contribution from a-carotene.
Plasma lycopene values were associated with case status only before plasma cholesterol and triglycerides were controlled in the analysis. Adjustment for the these lipids allowed observation of the independent effect of lycopene (or lack of an effect) after differences in lipid status and the association of the lipids with case status were eliminated. Stryker et al (32) demonstrated a better correlation between calorie-adjusted dietary intake of fat-soluble nutrients (carotenoids and tocopherols) and the lipid-adjusted concentrations of these nutrients in plasma compared with the unadjusted concentrations. Therefore, the inference of risk estimates from plasma data to dietary intake is stronger after the plasma variables are adjusted for these lipids.
Plasma retinal
The higher risk observed with higher retinol within the low P-carotene quartile is consistent with studies that associated breast cancer with low dietary intake of total vitamin A (23, 24) or P-carotene (17) and high plasma retinol (16) . The significance of the high plasma retinol is u nclear, perhaps it is a marker of particular dietary habits or other metabolic factors. Retinol has been positively associated with plasma estrogens (58) and, because estrogens may be associated with promotion of breast cancer, higher retinol concentrations may merely be a marker for the estrogenic environment or, perhaps, part of the mechanism by which estrogens exert their effect. Nonetheless, the pattern of risk observed suggests that P-carotene is not acting solely through its conversion to retinol. and that these two nutrients may have some interdependent functions in carcinogenesis. The lack of a main effect of plasma retinol and the presence of an interactive effect between plasma retinol and Pcarotene demonstrates the importance of evaluating n utritional interactions in studies of cancer etiology.
Dietary data
The results from the dietary data were consistent with one study that did not find an association between breast cancer and dietary Jj-carotene (16) . Other dietary studies (17, 23, 24) with larger sample sizes (451, 2024, and 120 cases. respectively) than the present study did show associations when dietary indicators of vitamin A or (j-carotene were used.
The questionnaire used in this study was an abbreviated form of a larger food frequency questionnaire. Although individuals should rank approximately the same by the use of either questionnaire, the abbreviated questionnaire may be more prone to misclassification than the more complete questionnaire. This misclassification would have more impact on small studies and therefore could account for the lack of findings.
Preliminary analysis of the reproducibility of the dietary data from this study suggests poor agreement in frequency categories between first and second questionnaires (59% exact agreement, 71% agreement plus or minus one frequency category). Thus, these dietary data included a large amount of variability that was unaccounted for, which biased the results toward the null hypothesis. The positive findings when the plasma indicators were used, the lack of a correlation between the plasma and dietary indicators of vitamin A, and the lack of reproducibility of the dietary data suggest that dietary indicators were not as sensitive as were plasma indicators. Therefore, a larger sample size would be required for the food frequency methodology employed here to be useful.
In conclusion, the findings concerning P-carotene are in accord with studies that found an association between low Jj-carotene concentrations and cancers of epithelial origin (59) . It is important to note, however, that high plasma P-carotene may also be a marker for carotene-rich foods so that other carotenes, or other constituents of these foods, may be the more important risk factors. Low plasma P-carotene in combination with high retinol was found to be associated with breast cancer, which was consistent with diets low in carotene-containing vegetables and may be a marker of a dietary pattern. These findings are consistent with the National Research Council's (60) dietary recommendations for increased consumption of fruits and vegetables. As interest in the association between nutrition and cancer rises (61 ) , additional studies of this type will be war- 
